These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 33851375)
1. Cannabis sativa and Skin Health: Dissecting the Role of Phytocannabinoids. Martinelli G; Magnavacca A; Fumagalli M; DellʼAgli M; Piazza S; Sangiovanni E Planta Med; 2022 Jun; 88(7):492-506. PubMed ID: 33851375 [TBL] [Abstract][Full Text] [Related]
2. The potential role of cannabinoids in dermatology. Sheriff T; Lin MJ; Dubin D; Khorasani H J Dermatolog Treat; 2020 Dec; 31(8):839-845. PubMed ID: 31599175 [TBL] [Abstract][Full Text] [Related]
3. Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment. Oláh A; Markovics A; Szabó-Papp J; Szabó PT; Stott C; Zouboulis CC; Bíró T Exp Dermatol; 2016 Sep; 25(9):701-7. PubMed ID: 27094344 [TBL] [Abstract][Full Text] [Related]
10. The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential. Coelho MP; Duarte P; Calado M; Almeida AJ; Reis CP; Gaspar MM Life Sci; 2023 Sep; 329():121838. PubMed ID: 37290668 [TBL] [Abstract][Full Text] [Related]
11. [New targeted compounds-biosynthesis of phytocannabinoids]. Gao P; Chen Y; Ke C; Yang X; Huang J Sheng Wu Gong Cheng Xue Bao; 2021 Jun; 37(6):1968-1985. PubMed ID: 34227288 [TBL] [Abstract][Full Text] [Related]
12. Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Nigro E; Formato M; Crescente G; Daniele A Molecules; 2021 May; 26(9):. PubMed ID: 34063214 [No Abstract] [Full Text] [Related]
13. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154 [TBL] [Abstract][Full Text] [Related]
14. Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors. Valdeolivas S; Satta V; Pertwee RG; Fernández-Ruiz J; Sagredo O ACS Chem Neurosci; 2012 May; 3(5):400-6. PubMed ID: 22860209 [TBL] [Abstract][Full Text] [Related]
15. Cannabidiol and Other Cannabinoids: From Toxicology and Pharmacology to the Development of a Regulatory Pathway. Koturbash I; MacKay D J Diet Suppl; 2020; 17(5):487-492. PubMed ID: 32715797 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol. Smeriglio A; Giofrè SV; Galati EM; Monforte MT; Cicero N; D'Angelo V; Grassi G; Circosta C Fitoterapia; 2018 Jun; 127():101-108. PubMed ID: 29427593 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological Properties of the Plant-Derived Natural products Cannabinoids and Implications for Cardiovascular Health. Liberale L; Montecucco F; Carbone F Adv Exp Med Biol; 2021; 1308():249-255. PubMed ID: 33861448 [TBL] [Abstract][Full Text] [Related]
18. Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action. Anil SM; Peeri H; Koltai H Front Pharmacol; 2022; 13():908198. PubMed ID: 35614947 [TBL] [Abstract][Full Text] [Related]
19. Phytocannabinoids and epilepsy. dos Santos RG; Hallak JE; Leite JP; Zuardi AW; Crippa JA J Clin Pharm Ther; 2015 Apr; 40(2):135-43. PubMed ID: 25475762 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]